Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 8Lymphoma, Non-Hodgkin 4Lymphoma 4Breast Neoplasms 4Pancreatic Neoplasms 3Neoplasms 3Lung Neoplasms 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Leukemia 2Hodgkin Disease 2Hematologic Neoplasms 2Esophageal Neoplasms 2Central Nervous System Neoplasms 2Burkitt Lymphoma 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Toxemia 1Thrombocythemia, Essential 1Stomach Neoplasms 1Sezary Syndrome 1

Interventions

Capecitabine 42Oxaliplatin 39Fluorouracil 29Leucovorin 23Radiotherapy 22Cetuximab 15Bevacizumab 15Irinotecan 13Nivolumab 12Magnetic Resonance Spectroscopy 11Specimen Handling 9Drug Therapy 9Surgical Procedures, Operative 8Folfox protocol 8pembrolizumab 7Radiotherapy, Intensity-Modulated 7Chemoradiotherapy 7Biopsy 7trifluridine tipiracil drug combination 6Radiation 6tislelizumab 5sintilimab 5regorafenib 5dehydroftorafur 5X-Rays 5Surveys and Questionnaires 5Sigmoidoscopy 5Endoscopy 5Consolidation Chemotherapy 5spartalizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Positron-Emission Tomography × 1 year × Clear all
NCT03745326 2026-05-19

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
5 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡